文献速递主动脉疾病

西班牙男女腹主动脉瘤人群筛查试点项目的可行性与效率研究

Feasibility and Efficiency Study of a Population-Based Abdominal Aortic Aneurysm Screening Program in Men and Women in Spain.
PubMed 文献 · Ann Vasc Surg · 2020-12-30

该研究在西班牙巴塞罗那地区开展基于人群的腹主动脉瘤超声筛查试点,邀请4730名65岁人群参与。男性参与率50.3%、女性44%,男性新检出AAA患病率0.5%(吸烟男性2.67%),女性未检出。成本效用模型显示筛查仅在30年时间跨度下具有效率。

要点

  • 基层医疗超声筛查AAA在后勤上可行,男性参与率50.3%、女性44%。
  • 65岁男性新检出AAA患病率0.5%,吸烟男性达2.67%,女性为0。
  • 成本效用模型显示筛查仅在30年时间跨度下具有效率。

核心结论

  • 基于基层医疗的超声AAA人群筛查在当地后勤可行,但男性患病率低于预期、女性为零。
  • 成本效用模型显示筛查仅在30年时间跨度下具有效率,人群筛查效率不佳需考虑机会性或亚组筛查策略。

研究设计与样本

  • 在巴塞罗那地区覆盖40万居民中开展的人群AAA筛查试点项目。
  • 邀请4730名65岁个体(男性2089名、女性2641名)参与筛查,由接受过腹部超声培训的基层医生进行腹主动脉测量。
  • 排除既往确诊AAA、预期寿命有限或联系方式错误的个体,分析参与率、主动脉直径、AAA患病率及相关心血管危险因素。
  • 结果用于成本效用模型评估筛查效率。

主要发现

  • 男性参与率50.3%,女性参与率44%。
  • 65岁男性新检出5例无症状AAA,患病率0.5%,均为 active smokers。
  • 计入既往确诊AAA排除者后,65岁男性患病率达1.4%。
  • 吸烟男性总体AAA患病率达2.67%;女性未检出AAA。

关键数值与推荐

  • 男性参与率50.3%,女性参与率44%。
  • 65岁男性新检出AAA患病率0.5%,计入排除者后达1.4%。
  • 吸烟男性AAA患病率2.67%,女性为0。
  • 男性亚动脉瘤主动脉患病率2.9%(n=29),女性0.08%(n=2)。
  • 成本效用:10年时间跨度13664€/QALY,30年时间跨度39455€/QALY。

临床怎么用

  • 在当地可考虑针对吸烟男性等亚组开展机会性或选择性AAA筛查,而非全人群筛查。
  • 基层医生经培训后可执行腹主动脉超声测量,筛查后勤可行。
  • 女性AAA患病率极低,人群筛查中 women 的获益需谨慎评估。

局限性

  • 研究为单地区试点,结果外推需谨慎。
  • 成本效用模型为基于本地数据的模拟,长期结果需验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Based on current evidence, one-time screening for abdominal aortic aneurysm (AAA) in men using ultrasound evaluation reduces mortality related to AAA rupture and is considered cost-effective, although all-cause mortality reduction still remains in question. In Spain, there is no population screening program for AAA, so the aim of our study was to perform a pilot population screening program in our area to assess feasibility and efficiency of an AAA screening program for men and women. METHODS: A population AAA screening pilot program was performed in a Barcelona area, including 400,000 inhabitants. According to inclusion criteria, 4,730 individuals aged 65 years at the moment of the trial were invited for screening (2,089 men and 2,641 women). Primary care doctors, trained in duplex ultrasound abdominal evaluations, performed an abdominal aortic measurement. Individuals with a previous diagnosis of AAA, limited life expectancy, or wrong contact data were excluded. Participation data, aortic diameters, AAA prevalence, and related cardiovascular risk factors were analyzed. The results were used in a cost-utility model to assess the efficiency of the screening program. RESULTS: Participation was 50.3% in men and 44% in women. Eleven patients were excluded because of previously diagnosed AAA. Five new asymptomatic AAA were detected in 65-year-old men (0.5% prevalence), all being active smokers. When considering patients excluded for previous AAA diagnosis, the prevalence in 65-year-old men reached 1.4%. Global AAA prevalence in smoking men reached 2.67%. No AAA was detected in women. Subaneurysmal aorta prevalence in men was 2.9% (n = 29), and in women, it was 0.08% (n = 2). A cost-utility analysis model on screening versus no screening retrieved 13,664€ per quality-adjusted life years at a 10-year horizon and 39,455€ per quality-adjusted life years at a 30-year horizon. CONCLUSIONS: AAA population-based screening by ultrasound evaluation in primary care is logistically feasible in our area. Despite that, AAA prevalence is lower than expected in men, and null in women. Cost-utility model results indicate that a local AAA screening program is only efficient in a 30 years' time horizon. Such inefficient results for a population screening make it necessary to consider other strategies such as opportunistic or subgroup screening in our area.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Fite J, Gayarre-Aguado R, Puig T, et al. Feasibility and Efficiency Study of a Population-Based Abdominal Aortic Aneurysm Screening Program in Men and Women in Spain. Ann Vasc Surg. 2020. PMID: 33387620. doi:10.1016/j.avsg.2020.11.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。